ClinicalTrials.gg
CompletedNCT07574281Updated Sep 11, 2026

Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in Ethiopia

An interventional study of DINKNESH App and Paper based tool in Palliative Care, sponsored by Addis Ababa University. Completed at 1 site in Ethiopia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Addis Ababa University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
1,152
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a digital health app called DINKNESH is effective for palliative care identification compared to traditional paper-based assessment tools. It will also look at the factors that help or hinder the use of this app in primary care settings.

The main questions it aims to answer are:

Does the DINKNESH app improve palliative care assessments compared to paper forms?

What are the main barriers and facilitators for Health Extension Workers when using the app in their daily work?

We will compare the DINKNESH app to standard paper-based tools to see if digital tools improve clinical assessment and implementation.

Participants will:

Be assessed for palliative care needs using either the DINKNESH mobile app or standard paper forms.

Receive routine follow-up care as determined by their health provider.

(For health workers): Participate in interviews or surveys to discuss their experience using the assigned assessment tool.

02

Conditions studied

  • Palliative Care
03

In context

Lead sponsor

Addis Ababa University is the lead sponsor of 19 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For patients(Quantitative Part):

    • Adults aged 18 years or older
    • Currently diagnosed with one or more chronic conditions and receiving home-based follow-up care from a participating Family Health Team within the catchment area of a selected study cluster
    • Willing to provide verbal , or has a primary caregiver willing to provide proxy consent
  • For healthcare workers:

    • Staff members of the Family Health Team at the selected clusters
    • Involved in delivering or supervising palliative care services during the study period
    • For the qualitative part: Participated in the DINKNESH App implementation process and is willing to participate in a Focus Group Discussion (FGD)

Exclusion criteria

Exclusion Criteria

  • For patients

    • Patients whose clinical condition prevents both self-participation and proxy participation in the assessment process
    • Patients already formally identified and referred for palliative care prior to the study period
  • For healthcare workers:

    • Staff members planning to be absent for more than 1 day during the six-week active study period
    • Healthworkers not present during the training session
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,152 participants (actual)

Study arms

  • Experimental
    DINKNESH App

    Healthcare workers (Family Health Teams) in these clusters will utilize the DINKNESH mobile application during routine home-based visits to systematically identify and assess patients requiring palliative care. The app integrates validated tools (SPICT, ECOG, IPOS) and provides clinical decision support for symptom management, counseling, and referral protocols

    Other: DINKNESH App

  • Active comparator
    Paper based Tool

    Family Health Teams in these clusters will provide home-based chronic care services following standard paper based without the use of the digital application.

    Other: Paper based tool

Interventions

  • OtherDINKNESH App

    A mobile-based digital health application designed to support Family Health Teams in the systematic identification and assessment of patients with palliative care needs. The application digitizes validated clinical tools, including the Supportive and Palliative Care Indicators Tool (SPICT), the Eastern Cooperative Oncology Group (ECOG) performance status, and the Integrated Palliative care Outcome Scale (IPOS) along with reference materials

  • OtherPaper based tool

    A paper-based clinical assessment protocol designed to support Family Health Teams in the systematic identification and assessment of patients with palliative care needs. It incorporates the same validated clinical tools used in the intervention arm, including the Supportive and Palliative Care Indicators Tool (SPICT), the Eastern Cooperative Oncology Group (ECOG) performance status, and the Integrated Palliative care Outcome Scale (IPOS), administered manually during routine home visits without the use of a digital application and reference material.

06

What researchers measure

Primary outcomes

  1. Rate of identification of patients with palliative care needs.

    The primary outcome is the rate of palliative care identifications, calculated as the number of individuals identified as requiring palliative care divided by the total number of chronic patient visit conducted by the Family Health Teams during the study period.

    Time frame: 6 weeks

Secondary outcomes

  1. Qualitative assessment of implementation barriers and enablers.

    Evaluation of implementation determinants (barriers and facilitators) through focus group discussions with health extension workers

    Time frame: 6 weeks

07

Study locations

1 site
  • Addis Ababa City Administration Health Bureau primary health centres (12 selected)
    Addis Ababa, 1000, Ethiopia
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2026 to primary completion in May 2026, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2026
First posted
May 7, 2026
StartActual
Apr 5, 2026
Primary completionActual
May 15, 2026
CompletionActual
May 15, 2026
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07574281
Lead sponsor
Addis Ababa University
Responsible party
Meheret Y. Amare (Dr, Addis Ababa University) — Principal investigator
First posted
May 7, 2026
Start date
Apr 5, 2026
Primary completion
May 15, 2026
Completion
May 15, 2026
Last update
Sep 11, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion